ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host disease.
- Resource Type
- Article
- Source
Internal Medicine Journal . Dec2023, Vol. 53 Issue 12, p2319-2329. 11p.- Subject
- *
STEROID drugs
*CONSENSUS (Social sciences)
*GRAFT versus host disease
*ADRENOCORTICAL hormones
*CHRONIC diseases
*HETEROCYCLIC compounds
*JANUS kinases
*HEMATOPOIETIC stem cell transplantation
*NEUROTRANSMITTER uptake inhibitors
*ACUTE diseases - Language
- ISSN
- 1444-0903